Home/ Stocks/ LENZ

LENZ Therapeutics, Inc. Common Stock

LENZ XNAS

$5.36 +0.14 (+2.71%) ▲ 15-min delayed

Open

$5.29

High

$5.42

Low

$5.21

Volume

452.8K

Market Cap

$163.67M

About LENZ Therapeutics, Inc. Common Stock

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 152 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$1.90M	$-41,488,000	$-1.32
FY 2025	$19.09M	$-82,127,000	$-2.85
Q3 2025	$12.50M	$-16,700,000	$-0.59
Q2 2025	$5.00M	$-14,912,000	$-0.53

Earnings & Analyst Ratings

Next Earnings: Tue, Nov 3, 2026

Calendar →

Related Market News

No specific coverage for LENZ yet. Check out our latest market news or earnings calendar.

Get LENZ Alerts

Stay ahead with breaking news, price alerts, and expert analysis on LENZ Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.